TARDBP and amyotrophic lateral sclerosis: Anti-sense oligonucleotides (ASO) can bind to mRNA and reduce protein expression, representing a potential therapeutic strategy (Bennett and Swayze, 2010), and using ASOs targeted at proteins such as SOD1 and TDP-43 can prevent protein aggregation and ALS.